Proceeds to drive development of ONP-002, the Company’s lead intranasal drug candidate for mild traumatic brain injurySARASOTA, Fla., July 02, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: ...

The Kansas City Royals celebrated Jac Caglianone’s first home run with the silent treatment in the clubhouse. Then, he hit another home run in a KC Royals win.